- Home
- FLYX vs ATNM Comparison
FLYX vs ATNM Comparison
Compare FLYX & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- ATNM
- Stock Information
- Founded
- FLYX 2015
- ATNM 2000
- Country
- FLYX United States
- ATNM United States
- Employees
- FLYX N/A
- ATNM N/A
- Industry
- FLYX Blank Checks
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- FLYX Finance
- ATNM Health Care
- Exchange
- FLYX Nasdaq
- ATNM Nasdaq
- Market Cap
- FLYX 54.1M
- ATNM 51.5M
- IPO Year
- FLYX N/A
- ATNM N/A
- Fundamental
- Price
- FLYX $2.06
- ATNM $1.43
- Analyst Decision
- FLYX
- ATNM Strong Buy
- Analyst Count
- FLYX 0
- ATNM 3
- Target Price
- FLYX N/A
- ATNM $4.67
- AVG Volume (30 Days)
- FLYX 19.7K
- ATNM 514.9K
- Earning Date
- FLYX 08-13-2025
- ATNM 08-04-2025
- Dividend Yield
- FLYX N/A
- ATNM N/A
- EPS Growth
- FLYX N/A
- ATNM N/A
- EPS
- FLYX N/A
- ATNM N/A
- Revenue
- FLYX $335,427,000.00
- ATNM N/A
- Revenue This Year
- FLYX $28.47
- ATNM N/A
- Revenue Next Year
- FLYX $22.44
- ATNM N/A
- P/E Ratio
- FLYX N/A
- ATNM N/A
- Revenue Growth
- FLYX 5.38
- ATNM N/A
- 52 Week Low
- FLYX $1.79
- ATNM $1.03
- 52 Week High
- FLYX $5.19
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- FLYX 34.41
- ATNM 44.02
- Support Level
- FLYX $1.90
- ATNM $1.41
- Resistance Level
- FLYX $2.89
- ATNM $1.95
- Average True Range (ATR)
- FLYX 0.30
- ATNM 0.12
- MACD
- FLYX -0.06
- ATNM -0.03
- Stochastic Oscillator
- FLYX 15.33
- ATNM 22.22
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.